Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Free Cash Flow (2020 - 2025)

Agilon Health's Free Cash Flow history spans 6 years, with the latest figure at -$23.5 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 278.7% year-over-year to -$23.5 million; the TTM value through Dec 2025 reached -$119.0 million, down 67.55%, while the annual FY2025 figure was -$119.0 million, 67.55% down from the prior year.
  • Free Cash Flow reached -$23.5 million in Q4 2025 per AGL's latest filing, down from -$21.3 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $13.2 million in Q4 2024 to a low of -$65.1 million in Q4 2023.
  • Average Free Cash Flow over 5 years is -$33.2 million, with a median of -$31.6 million recorded in 2022.
  • Peak YoY movement for Free Cash Flow: crashed 2076.21% in 2023, then surged 120.2% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at -$52.3 million in 2021, then fell by 2.2% to -$53.4 million in 2022, then dropped by 21.8% to -$65.1 million in 2023, then skyrocketed by 120.2% to $13.2 million in 2024, then tumbled by 278.7% to -$23.5 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Free Cash Flow are -$23.5 million (Q4 2025), -$21.3 million (Q3 2025), and -$38.3 million (Q2 2025).